Allavena P, Belgiovine C, D’Incalci M, et al. 2022 Effects of the anti-tumour agents trabectedin and lurbinectedin on immune cells of the tumour microenvironment. Front. Oncol. 12 851790
Article CAS PubMed PubMed Central Google Scholar
Anderson NR, Minutolo NG, Klichinsky M, et al. 2021 Macrophage-based approaches for cancer immunotherapy. Cancer Res. 81 1201–1208
Article CAS PubMed Google Scholar
Anfray C, Ummarino A, Allavena P, et al. 2020 Current strategies to target tumour-associated-macrophages to improve anti-tumor immune responses. Cells 9 46
Argyle D and Kitamura T 2018 Targeting macrophage-recruiting chemokines as a novel therapeutic strategy to prevent the progression of solid tumours. Front. Immunol. 9 2629
Article PubMed PubMed Central Google Scholar
Belgiovine C, Bello E, Liguori M, et al. 2017 Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models. Br. J. Cancer 117 628–638
Article CAS PubMed PubMed Central Google Scholar
Bercovici N, Guérin MV, Trautmann A, et al. 2019 The remarkable plasticity of macrophages: A chance to fight cancer. Front. Immunol. 10 1563
Article CAS PubMed PubMed Central Google Scholar
Boutilier AJ and Elsawa SF 2021 Macrophage polarization states in the tumour microenvironment. Int. J. Mol Sci. 22 6995
Article CAS PubMed PubMed Central Google Scholar
Cai H, Zhang Y, Wang J, et al. 2021 Defects in macrophage reprogramming in cancer therapy: the negative impact of PD-L1/PD-1. Front. Immunol. 12 690869
Article CAS PubMed PubMed Central Google Scholar
Canton J 2014 Phagosome maturation in polarized macrophages. J. Leukoc. Biol. 96 729–738
Chen Y, Yu Z, Tan X, et al. 2021 CAR-macrophage: A new immunotherapy candidate against solid tumors. Biomed. Pharmacother. 139 111605
Article CAS PubMed Google Scholar
Conde J, Bao C, Tan Y, et al. 2015 Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells. Adv. Funct. Mater. 25 4183–4194
Article CAS PubMed PubMed Central Google Scholar
Coussens LM, Zitvogel L and Palucka AK 2013 Neutralizing tumour-promoting chronic inflammation: a magic bullet? Science 339 286–291
Article CAS PubMed PubMed Central Google Scholar
Dumoulin DW, Visser S, Cornelissen R, et al. 2022 Renal toxicity from pemetrexed and pembrolizumab in the era of combination therapy in patients with metastatic nonsquamous cell NSCLC. Eur. J. Cancer 172 357–366
Article CAS PubMed Google Scholar
Fujiwara T, Chandler A, Yoshida A, et al. 2021 CSF1/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumour-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol. Cancer Ther. 20 1388–1399
Article CAS PubMed PubMed Central Google Scholar
Germano G, Frapolli R, Belgiovine C, et al. 2013 Role of macrophage targeting in the anti-tumour activity of trabectedin. Cancer Cell 23 249–262
Article CAS PubMed Google Scholar
Gordon S 2003 Alternative activation of macrophages. Nat. Rev. Immunol. 3 23–35
Article CAS PubMed Google Scholar
Gustafson HH, Holt-Casper D, Ghandehari H, et al. 2015 Nanoparticle uptake: the phagocyte problem. Nano Today 10 487–510
Article CAS PubMed PubMed Central Google Scholar
Haber T, Flores L, Cao P, et al. 2020 Specific targeting of ovarian tumour-associated macrophages by large, anionic nanoparticles. Proc. Natl. Acad. Sci. USA 117 19737–19745
Article CAS PubMed PubMed Central Google Scholar
He Z and Zhang S 2021 Tumour-associated macrophages and their functional transformation in the hypoxic tumour microenvironment. Front. Immunol. 12 741305
Article CAS PubMed PubMed Central Google Scholar
Hourani T, Holden JA, O’Brien-Simpson NM, et al. 2021 Tumour-associated macrophages: origin, recruitment, phenotypic diversity, and targeting. Front. Oncol. 11 788365
Article CAS PubMed PubMed Central Google Scholar
Hume DA and MacDonald KPA 2012 Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signalling. Blood 119 1810–1820
Article CAS PubMed Google Scholar
Jakubzick CV, Randolph GJ and Henson PM 2017 Monocyte differentiation and antigen-presenting functions. Nat. Rev. Immunol. 17 349–362
Article CAS PubMed Google Scholar
Jiang P, Lagenaur CF and Narayanan V 1999 Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 274 559–562
Article CAS PubMed Google Scholar
Lampiasi N, Russo R and Zito F 2016 The alternative faces of macrophage generate osteoclasts. Biomed. Res. Int. 2016 9089610
Article CAS PubMed PubMed Central Google Scholar
Larsen AK, Galmarini CM and D’Incalci M 2016 Trabectedin mechanism of action: what’s new? Cancer Chemother. Pharmacol. 77 663–671
Article CAS PubMed Google Scholar
Li X, Yao W, Chen P, et al. 2017 Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66 157–167
Article CAS PubMed Google Scholar
Li G, Liu D, Qi X, et al. 2018 Nanoliposome C6-ceramide increases the anti-tumour immune response and slows growth of liver tumours in mice. Gastroenterology 154 1024-1036.e9
Article CAS PubMed Google Scholar
Li C, Xu X, Wang J, et al. 2021 Tumour-associated macrophages: potential therapeutic strategies and future prospects in cancer. J. Immunother. Cancer 9 e001314
Li Z, Ding Y, Liu J, et al. 2022 Depletion of tumour-associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumour recurrence treatment. Nat. Commun. 13 1845
Article CAS PubMed PubMed Central Google Scholar
Lin Y, Xu J and Lan H 2019 Tumour-associated macrophages in tumour metastasis: biological roles and clinical therapeutic applications. J. Hematol. Oncol. 12 76
Article PubMed PubMed Central Google Scholar
MacParland SA, Tsoi KM, Manuel J, et al. 2017 Phenotype determines nanoparticle uptake by human macrophages from liver and blood. ACS Nano 11 2428–2443
Article CAS PubMed Google Scholar
Mantovani A, Marchesi F, Allavena P, et al. 2021 Tumour-associated myeloid cells: diversity and therapeutic targeting. Cell Mol. Immunol. 18 566–578
Article CAS PubMed PubMed Central Google Scholar
Mantovani A, Allavena P, Marchesi F, et al. 2022 Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21 799–820
Article CAS PubMed PubMed Central Google Scholar
Moreau MF, Guillet C, Massin P, et al. 2007 Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem. Pharmacol. 73 718–723
Article CAS PubMed Google Scholar
Murray PJ, Allen JE, Biswas SK, et al. 2014 Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41 14–20
Article CAS PubMed PubMed Central Google Scholar
Nishida-Aoki N and Gujral TS 2022 Polypharmacologic reprogramming of tumour-associated macrophages toward an inflammatory phenotype. Cancer Res. 82 433–446
留言 (0)